Kadmon (KDMN) raised $75 million (53% insider) on its IPO and proceeded to drop 19% on Wednesday, the year's second-worst debut. Kadmon is only the latest in a string of biotech IPOs that have disappointed. Of the 12 biotechs that have IPO'd...read more
The shortened holiday week saw three healthcare IPOs raise over $150 million, bringing the year-to-date total up to 34 offerings. Can't stop Nant: NantHealth surges 33% in year's second-best IPO debut Billionaire founder and CEO Patrick...read more
NantHealth, which provides healthcare data solutions and plans to launch a new cancer diagnostic, raised $91 million by offering 6.5 million shares at $14, the midpoint of the range of $12.50 to $15.50. Existing shareholders, including CEO Patrick...read more
The shortened holiday week ahead will see two deals come to market, raising just over $100 million combined. Coming off 15 pricings in May, the seasonally strong June should see similar or improved market activity. ...read more
Kadmon plummets 19% on offering; 10 of 12 biotech IPOs since April 1 are below issue
Kadmon (KDMN) raised $75 million (53% insider) on its IPO and proceeded to drop 19% on Wednesday, the year's second-worst debut. Kadmon is only the latest in a string of biotech IPOs that have disappointed. Of the 12 biotechs that have IPO'd...read more
US IPO Weekly Recap: Three healthcare IPOs led by billionaire-backed NantHealth's +33% pop
The shortened holiday week saw three healthcare IPOs raise over $150 million, bringing the year-to-date total up to 34 offerings. Can't stop Nant: NantHealth surges 33% in year's second-best IPO debut Billionaire founder and CEO Patrick...read more
Next-generation cancer diagnosis: NantHealth prices $91 million IPO at $14 midpoint
NantHealth, which provides healthcare data solutions and plans to launch a new cancer diagnostic, raised $91 million by offering 6.5 million shares at $14, the midpoint of the range of $12.50 to $15.50. Existing shareholders, including CEO Patrick...read more
US IPO Week Ahead: Billionaire doctor back with another IPO
The shortened holiday week ahead will see two deals come to market, raising just over $100 million combined. Coming off 15 pricings in May, the seasonally strong June should see similar or improved market activity. ...read more